Remember
 
 
At SpeculatingStocks You Can Discover Stocks, Post Anonymously, and React to Posts. Login is Optional.
Watch for Reactions to Your Posts or React Below to Other's Posts. Discover Stocks and Market Data.
     
 

February 7, 2008

SpeculatingStocks.com Stock Pick: Cleveland BioLabs, Inc. (CBLI)

Stock Price: $4.34


Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Radiobiology Research Institute.

CBLI recently dropped from the $8.00 level to the $3.00 level and has since began to trend higher. The company lost out on a defense contract for their proposed treatment for the gastrointestinal effects of radiation sickness. CBLI plans to continue developing its treatment, aiming for regulartory approval by 2009, and the company intends on responding to any future DoD solicitations.

CBLI is trading at a market cap of only around $52.87 million and has a strong balance sheet with cash, cash equivalents and short term investments of $21.28 million and no long-term debt.

There are only 6.81 million shares in the CBLI float. We believe is undervalued and will be able to rebound.

 
     
Untitled Document